PortViewPortView
Orexigen Therapeutics logo

Orexigen Therapeutics (OREX) Stock Analysis

NASDAQHealthcareMedical - Pharmaceuticals

$0.22-9.87%
52-week range$0.22
$0.17$3.81

What Orexigen Therapeutics does

Orexigen Therapeutics, Inc. (NASDAQ: OREX) is a Medical - Pharmaceuticals company in the Healthcare sector.

Key metrics

Market cap
$0
P/E (TTM)
-0.14
EPS (TTM)
$-1.62
Beta
5.60
Dividend yield
0.00%
Revenue / share
$2.22
50-day avg
$0.82
200-day avg
$1.73
52-week high
$3.81
52-week low
$0.17

ETFs linked to OREX

Broad-market and Healthcare sector ETFs an investor holding Orexigen Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how OREX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze OREX in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Orexigen Therapeutics?
Orexigen Therapeutics trades under the ticker OREX on NASDAQ.
Which exchange is OREX listed on?
OREX is listed on NASDAQ.
What sector does Orexigen Therapeutics operate in?
Orexigen Therapeutics is classified in the Healthcare sector (Medical - Pharmaceuticals industry).
How can PortView help analyze OREX in a portfolio?
PortView shows OREX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.